Insiders · QURE

QURE insider transactions

uniQure N.V. (QURE) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

QURE insiders

Everyone who has filed a Form 3, 4, 5 or 144 at uniQure N.V., latest first. Follow anyone to get their next filing.

• David D. MeekDirector-$369K
• Walid Abi-SaabChief Medical Officer, since September 2023-$2.65M
• Matthew C KapustaCEO, Managing Director-$29.1M
• Jack KayeDirector-$2.82M
• Madhavan BalachandranDirector-$981K
• Jeannette PottsChief Legal Officer, since June 2023-$428K
• Robert GutDirector-$2.23M
• Kylie O'KeefeChief Customer & Strat Officer, since February 2026-$431K
• Jeremy P. SpringhornDirector-$176K
• Leonard E PostDirector-$160K
• Rachelle Suzanne JacquesDirector, since October 2021-$147K
• Christian KlemtChief Financial Officer-$2.7M
• Pierre CalozChief Operating Officer, since June 2021-$574K
• Paula SoteropoulosDirector-$544K
• Ricardo DolmetschOfficer-$591K
• Alexander Edward Kuta IIIOfficer-$3.5M
• Philip Astley-SparkeDirector-$19K

Recent Form 3, 4, and 5 filings for QURE

• 2d
  Director Meek David D. sold $192,950 worth of Ordinary Shares (9,080 units at $21.25) as part of a pre-agreed trading plan, decreasing direct ownership by 23% to 30,667 units (SEC Form 4)

  4 - uniQure N.V. (0001590560) (Issuer)
• 9d
  Chief Medical Officer Abi-Saab Walid was granted 18,750 units of Ordinary Shares, increasing direct ownership by 13% to 166,985 units (SEC Form 4)

  4 - uniQure N.V. (0001590560) (Issuer)
• 128d
  CEO, Managing Director Kapusta Matthew C exercised 21,082 units of Ordinary Shares at a strike of $19.39 and sold $952,051 worth of Ordinary Shares (21,082 units at $45.16) as part of a pre-agreed trading plan (SEC Form 4)

  4 - uniQure N.V. (0001590560) (Issuer)
• 133d
  Chief Medical Officer Abi-Saab Walid exercised 10,000 units of Ordinary Shares at a strike of $5.59 and sold $1,392,600 worth of Ordinary Shares (30,000 units at $46.42) as part of a pre-agreed trading plan, decreasing direct ownership by 12% to 148,235 units (SEC Form 4)

  4 - uniQure N.V. (0001590560) (Issuer)
• 133d
  Director Kaye Jack exercised 21,167 units of Ordinary Shares at a strike of $23.44 and sold $983,030 worth of Ordinary Shares (21,167 units at $46.44) as part of a pre-agreed trading plan (SEC Form 4)

  4 - uniQure N.V. (0001590560) (Issuer)
• 135d
  Chief Medical Officer Abi-Saab Walid sold $67,197 worth of Ordinary Shares (1,434 units at $46.86), decreasing direct ownership by 0.85% to 168,235 units (SEC Form 4) (for withholding tax)

  4 - uniQure N.V. (0001590560) (Issuer)
• 139d
  CEO, Managing Director Kapusta Matthew C exercised 32,844 units of Ordinary Shares at a strike of $31.71 and sold $1,771,174 worth of Ordinary Shares (35,412 units at $50.02) as part of a pre-agreed trading plan, decreasing direct ownership by 0.49% to 519,227 units (SEC Form 4)

  4 - uniQure N.V. (0001590560) (Issuer)
• 143d
  CEO, Managing Director Kapusta Matthew C exercised 67,237 units of Ordinary Shares at a strike of $20.24 and sold $9,371,612 worth of Ordinary Shares (206,100 units at $45.47) as part of a pre-agreed trading plan, decreasing direct ownership by 21% to 521,795 units (SEC Form 4)

  4 - uniQure N.V. (0001590560) (Issuer)
• 144d
  Director Balachandran Madhavan exercised 11,685 units of Ordinary Shares at a strike of $24.97 and sold $526,485 worth of Ordinary Shares (11,685 units at $45.06) as part of a pre-agreed trading plan (SEC Form 4)

  4 - uniQure N.V. (0001590560) (Issuer)
• 144d
  Director Kaye Jack exercised 5,295 units of Ordinary Shares at a strike of $31.71 and sold $225,408 worth of Ordinary Shares (5,295 units at $42.57) as part of a pre-agreed trading plan (SEC Form 4)

  4 - uniQure N.V. (0001590560) (Issuer)
• 148d
  Director Balachandran Madhavan exercised 10,000 units of Ordinary Shares at a strike of $8.49 and sold $278,500 worth of Ordinary Shares (10,000 units at $27.85) as part of a pre-agreed trading plan (SEC Form 4)

  4 - uniQure N.V. (0001590560) (Issuer)
• 148d
  Chief Legal Officer Potts Jeannette sold $144,908 worth of Ordinary Shares (5,237 units at $27.67), decreasing direct ownership by 4% to 133,246 units (SEC Form 4) to satisfy tax liability

  4 - uniQure N.V. (0001590560) (Issuer)
• 153d
  Director Meek David D. was granted 7,550 units of Ordinary Shares and sold $53,931 worth of Ordinary Shares (1,993 units at $27.06), increasing direct ownership by 16% to 39,747 units (SEC Form 4) (for withholding tax)

  4 - uniQure N.V. (0001590560) (Issuer)
• 153d
  Director Gut Robert exercised 2,645 units of Ordinary Shares at a strike of $16.04, sold $270,486 worth of Ordinary Shares (10,278 units at $26.32) as part of a pre-agreed trading plan and was granted 7,550 units of Ordinary Shares, decreasing direct ownership by 0.26% to 32,259 units (SEC Form 4) (withholding tax)

  4 - uniQure N.V. (0001590560) (Issuer)
• 153d
  Chief Customer & Strat Officer O'Keefe Kylie sold $431,228 worth of Ordinary Shares (15,936 units at $27.06), decreasing direct ownership by 13% to 108,864 units (SEC Form 4) (for tax liability)

  4 - uniQure N.V. (0001590560) (Issuer)
• 153d
  Director Springhorn Jeremy P. was granted 7,550 units of Ordinary Shares and sold $53,931 worth of Ordinary Shares (1,993 units at $27.06), increasing direct ownership by 15% to 43,251 units (SEC Form 4) to satisfy withholding tax

  4 - uniQure N.V. (0001590560) (Issuer)
• 153d
  Director Post Leonard E was granted 7,550 units of Ordinary Shares and sold $53,931 worth of Ordinary Shares (1,993 units at $27.06), increasing direct ownership by 19% to 35,494 units (SEC Form 4) (tax withholding)

  4 - uniQure N.V. (0001590560) (Issuer)
• 153d
  Director Kaye Jack was granted 7,550 units of Ordinary Shares and sold $53,931 worth of Ordinary Shares (1,993 units at $27.06), increasing direct ownership by 27% to 25,996 units (SEC Form 4) (tax withholding)

  4 - uniQure N.V. (0001590560) (Issuer)
• 153d
  Director Jacques Rachelle Suzanne was granted 7,550 units of Ordinary Shares and sold $53,931 worth of Ordinary Shares (1,993 units at $27.06), increasing direct ownership by 20% to 33,903 units (SEC Form 4) (for tax liability)

  4 - uniQure N.V. (0001590560) (Issuer)
• 153d
  Director Balachandran Madhavan sold $53,931 worth of Ordinary Shares (1,993 units at $27.06) and was granted 7,550 units of Ordinary Shares, increasing direct ownership by 15% to 43,254 units (SEC Form 4) to satisfy tax liability

  4 - uniQure N.V. (0001590560) (Issuer)
• 160d
  Director Kaye Jack exercised 2,645 units of Ordinary Shares at a strike of $16.04 and sold $79,376 worth of Ordinary Shares (2,645 units at $30.01) as part of a pre-agreed trading plan (SEC Form 4)

  4 - uniQure N.V. (0001590560) (Issuer)
• 184d
  Chief Medical Officer Abi-Saab Walid exercised 25,000 units of Ordinary Shares at a strike of $5.59 and sold $1,127,500 worth of Ordinary Shares (45,000 units at $25.06) as part of a pre-agreed trading plan, decreasing direct ownership by 11% to 169,669 units (SEC Form 4)

  4 - uniQure N.V. (0001590560) (Issuer)
• 248d
  Chief Customer & Strat Officer O'Keefe Kylie was granted 19,800 units of Ordinary Shares, increasing direct ownership by 19% to 124,800 units (SEC Form 4)

  4 - uniQure N.V. (0001590560) (Issuer)
• 248d
  New insider O'Keefe Kylie claimed ownership of 105,000 units of Ordinary Shares (SEC Form 3)

  3 - uniQure N.V. (0001590560) (Issuer)
• 251d
  CEO, Managing Director Kapusta Matthew C was granted 70,600 units of Ordinary Shares and sold $132,104 worth of Ordinary Shares (14,581 units at $9.06), increasing direct ownership by 9% to 660,658 units (SEC Form 4)

  4 - uniQure N.V. (0001590560) (Issuer)
• 251d
  Chief Medical Officer Abi-Saab Walid sold $7,320 worth of Ordinary Shares (808 units at $9.06) and was granted 41,700 units of Ordinary Shares, increasing direct ownership by 27% to 189,669 units (SEC Form 4)

  4 - uniQure N.V. (0001590560) (Issuer)
• 251d
  Chief Legal Officer Potts Jeannette was granted 35,400 units of Ordinary Shares and sold $30,913 worth of Ordinary Shares (3,412 units at $9.06), increasing direct ownership by 30% to 138,483 units (SEC Form 4)

  4 - uniQure N.V. (0001590560) (Issuer)
• 251d
  Chief Financial Officer Klemt Christian was granted 39,600 units of Ordinary Shares and sold $108,720 worth of Ordinary Shares (12,000 units at $9.06), increasing direct ownership by 14% to 226,581 units (SEC Form 4)

  4 - uniQure N.V. (0001590560) (Issuer)
• 253d
  CEO, Managing Director Kapusta Matthew C sold $342,648 worth of Ordinary Shares (34,437 units at $9.95), decreasing direct ownership by 5% to 604,639 units (SEC Form 4)

  4 - uniQure N.V. (0001590560) (Issuer)
• 253d
  Chief Financial Officer Klemt Christian sold $124,693 worth of Ordinary Shares (12,532 units at $9.95), decreasing direct ownership by 6% to 198,981 units (SEC Form 4)

  4 - uniQure N.V. (0001590560) (Issuer)
• 253d
  Chief Legal Officer Potts Jeannette sold $85,351 worth of Ordinary Shares (8,578 units at $9.95), decreasing direct ownership by 7% to 106,495 units (SEC Form 4)

  4 - uniQure N.V. (0001590560) (Issuer)
• 253d
  Chief Medical Officer Abi-Saab Walid sold $16,517 worth of Ordinary Shares (1,660 units at $9.95), decreasing direct ownership by 1% to 148,777 units (SEC Form 4)

  4 - uniQure N.V. (0001590560) (Issuer)
• 258d
  CEO, Managing Director Kapusta Matthew C sold $295,339 worth of Ordinary Shares (12,378 units at $23.86), decreasing direct ownership by 2% to 639,076 units (SEC Form 4)

  4 - uniQure N.V. (0001590560) (Issuer)
• 258d
  Chief Financial Officer Klemt Christian sold $148,338 worth of Ordinary Shares (6,217 units at $23.86), decreasing direct ownership by 3% to 211,513 units (SEC Form 4)

  4 - uniQure N.V. (0001590560) (Issuer)
• 302d
  Director Gut Robert exercised 17,810 units of Ordinary Shares at a strike of $14.08 and sold $630,483 worth of Ordinary Shares (25,613 units at $24.62), decreasing direct ownership by 19% to 32,342 units (SEC Form 4)

  4 - uniQure N.V. (0001590560) (Issuer)
• 304d
  Director Kaye Jack exercised 6,390 units of Ordinary Shares at a strike of $19.39 and sold $174,319 worth of Ordinary Shares (6,390 units at $27.28) (SEC Form 4)

  4 - uniQure N.V. (0001590560) (Issuer)
• 367d
  Director Gut Robert exercised 15,840 units of Ordinary Shares at a strike of $4.57 and sold $856,881 worth of Ordinary Shares (31,434 units at $27.26), decreasing direct ownership by 28% to 40,145 units (SEC Form 4)

  4 - uniQure N.V. (0001590560) (Issuer)
• 371d
  Director Kaye Jack sold $1,177,517 worth of Ordinary Shares (38,810 units at $30.34) and exercised 38,810 units of Ordinary Shares at a strike of $9.88 (SEC Form 4)

  4 - uniQure N.V. (0001590560) (Issuer)
• 412d
  CEO, Managing Director Kapusta Matthew C exercised 226,316 units of Ordinary Shares at a strike of $6.52 and sold $9,382,473 worth of Ordinary Shares (226,316 units at $41.46) (SEC Form 4)

  4 - uniQure N.V. (0001590560) (Issuer)
• 412d
  Chief Financial Officer Klemt Christian exercised 18,000 units of Ordinary Shares at a strike of $6.65 and sold $945,120 worth of Ordinary Shares (18,000 units at $52.51) (SEC Form 4)

  4 - uniQure N.V. (0001590560) (Issuer)
• 499d
  Chief Medical Officer Abi-Saab Walid sold $20,407 worth of Ordinary Shares (1,466 units at $13.92), decreasing direct ownership by 0.97% to 150,437 units (SEC Form 4)

  4 - uniQure N.V. (0001590560) (Issuer)
• 506d
  Director Springhorn Jeremy P. sold $30,518 worth of Ordinary Shares (2,112 units at $14.45), decreasing direct ownership by 5% to 37,694 units (SEC Form 4)

  4 - uniQure N.V. (0001590560) (Issuer)
• 506d
  Director Post Leonard E sold $30,518 worth of Ordinary Shares (2,112 units at $14.45), decreasing direct ownership by 7% to 29,937 units (SEC Form 4)

  4 - uniQure N.V. (0001590560) (Issuer)
• 506d
  Director Kaye Jack sold $30,518 worth of Ordinary Shares (2,112 units at $14.45), decreasing direct ownership by 9% to 20,439 units (SEC Form 4)

  4 - uniQure N.V. (0001590560) (Issuer)
• 506d
  Director Jacques Rachelle Suzanne sold $30,518 worth of Ordinary Shares (2,112 units at $14.45), decreasing direct ownership by 7% to 28,346 units (SEC Form 4)

  4 - uniQure N.V. (0001590560) (Issuer)
• 506d
  Director Gut Robert sold $48,205 worth of Ordinary Shares (3,336 units at $14.45), decreasing direct ownership by 6% to 56,879 units (SEC Form 4)

  4 - uniQure N.V. (0001590560) (Issuer)
• 506d
  Director Balachandran Madhavan sold $30,518 worth of Ordinary Shares (2,112 units at $14.45), decreasing direct ownership by 5% to 37,697 units (SEC Form 4)

  4 - uniQure N.V. (0001590560) (Issuer)
• 506d
  Director Meek David D. sold $30,518 worth of Ordinary Shares (2,112 units at $14.45), decreasing direct ownership by 6% to 34,190 units (SEC Form 4)

  4 - uniQure N.V. (0001590560) (Issuer)
• 510d
  Chief Legal Officer Potts Jeannette sold $70,704 worth of Ordinary Shares (4,670 units at $15.14), decreasing direct ownership by 4% to 115,073 units (SEC Form 4)

  4 - uniQure N.V. (0001590560) (Issuer)
• 517d
  Director Post Leonard E was granted 7,970 units of Ordinary Shares, increasing direct ownership by 33% to 32,049 units (SEC Form 4)

  4 - uniQure N.V. (0001590560) (Issuer)
• 517d
  Director Kaye Jack was granted 7,970 units of Ordinary Shares, increasing direct ownership by 55% to 22,551 units (SEC Form 4)

  4 - uniQure N.V. (0001590560) (Issuer)
• 517d
  Director Jacques Rachelle Suzanne was granted 7,970 units of Ordinary Shares, increasing direct ownership by 35% to 30,458 units (SEC Form 4)

  4 - uniQure N.V. (0001590560) (Issuer)
• 517d
  Director Gut Robert was granted 7,970 units of Ordinary Shares, increasing direct ownership by 15% to 60,215 units (SEC Form 4)

  4 - uniQure N.V. (0001590560) (Issuer)
• 517d
  Director Balachandran Madhavan was granted 7,970 units of Ordinary Shares, increasing direct ownership by 25% to 39,809 units (SEC Form 4)

  4 - uniQure N.V. (0001590560) (Issuer)
• 517d
  Director Springhorn Jeremy P. was granted 7,970 units of Ordinary Shares, increasing direct ownership by 25% to 39,806 units (SEC Form 4)

  4 - uniQure N.V. (0001590560) (Issuer)
• 517d
  Director Meek David D. was granted 7,970 units of Ordinary Shares, increasing direct ownership by 28% to 36,302 units (SEC Form 4)

  4 - uniQure N.V. (0001590560) (Issuer)
• 617d
  CEO, Managing Director Kapusta Matthew C was granted 99,000 units of Ordinary Shares and sold $291,629 worth of Ordinary Shares (28,341 units at $10.29), increasing direct ownership by 12% to 651,454 units (SEC Form 4)

  4 - uniQure N.V. (0001590560) (Issuer)
• 617d
  Chief Medical Officer Abi-Saab Walid was granted 38,000 units of Ordinary Shares and sold $13,891 worth of Ordinary Shares (1,350 units at $10.29), increasing direct ownership by 32% to 151,903 units (SEC Form 4)

  4 - uniQure N.V. (0001590560) (Issuer)
• 617d
  Chief Financial Officer Klemt Christian was granted 73,000 units of Ordinary Shares and sold $107,407 worth of Ordinary Shares (10,438 units at $10.29), increasing direct ownership by 40% to 217,730 units (SEC Form 4)

  4 - uniQure N.V. (0001590560) (Issuer)
• 617d
  Chief Legal Officer Potts Jeannette was granted 35,000 units of Ordinary Shares and sold $72,812 worth of Ordinary Shares (7,076 units at $10.29), increasing direct ownership by 30% to 119,743 units (SEC Form 4)

  4 - uniQure N.V. (0001590560) (Issuer)